(Adding categories) |
(Adding categories) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 7: | Line 7: | ||
This draft guidance is intended to describe [[FDA]]'s current thinking about how manufacturers, packers, and distributors (firms) of prescription human and animal drugs (drugs) and [[medical device]]s for human use (devices) that choose to present benefit [[information]] should present both benefit and risk [[information]] within [[advertising]] and [[promotional]] labeling of their [[FDA]]-regulated medical products on [[electronic]]/[[digital]] [[platform]]s that are associated with [[character]] space limitations — specifically on the [[Internet]] and through [[social media]] or other [[technological]] venues ([[Internet]]/[[social media]]). |
This draft guidance is intended to describe [[FDA]]'s current thinking about how manufacturers, packers, and distributors (firms) of prescription human and animal drugs (drugs) and [[medical device]]s for human use (devices) that choose to present benefit [[information]] should present both benefit and risk [[information]] within [[advertising]] and [[promotional]] labeling of their [[FDA]]-regulated medical products on [[electronic]]/[[digital]] [[platform]]s that are associated with [[character]] space limitations — specifically on the [[Internet]] and through [[social media]] or other [[technological]] venues ([[Internet]]/[[social media]]). |
||
| − | Examples of [[Internet]]/[[social media]] [[platform]]s with character space limitations include [[online]] [[microblog messaging]] (e.g., [[message]]s on [[Twitter]] or "[[tweets]]," which are currently limited to 140 [[character]] spaces per [[tweet]]) and [[online]] [[paid search]] (e.g., "[[sponsored link]]s on [[search engine]]s such as [[Google]] and [[Yahoo]], which have limited [[character]] spaces as well as other [[platform]]-imposed considerations). |
+ | Examples of [[Internet]]/[[social media]] [[platform]]s with character space limitations include [[online]] [[microblog messaging]] (e.g., [[message]]s on [[Twitter]] or "[[tweets]]," which are currently limited to 140 [[character]] spaces per [[tweet]]) and [[online]] [[paid search]] (e.g., "[[sponsored link]]s" on [[search engine]]s such as [[Google]] and [[Yahoo]], which have limited [[character]] spaces as well as other [[platform]]-imposed considerations). |
[[Category:Publication]] |
[[Category:Publication]] |
||
[[Category:FDA]] |
[[Category:FDA]] |
||
| Line 13: | Line 13: | ||
[[Category:Social media]] |
[[Category:Social media]] |
||
[[Category:Internet]] |
[[Category:Internet]] |
||
| + | [[Category:2014]] |
||
Latest revision as of 14:48, 27 June 2014
Citation[]
U.S. Food and Drug Administration, Guidance for Industry: Internet/Social Media Platforms with Character Space Limitations-Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices (Draft) (June 18, 2014) (full-text).
Overview[]
This draft guidance is intended to describe FDA's current thinking about how manufacturers, packers, and distributors (firms) of prescription human and animal drugs (drugs) and medical devices for human use (devices) that choose to present benefit information should present both benefit and risk information within advertising and promotional labeling of their FDA-regulated medical products on electronic/digital platforms that are associated with character space limitations — specifically on the Internet and through social media or other technological venues (Internet/social media).
Examples of Internet/social media platforms with character space limitations include online microblog messaging (e.g., messages on Twitter or "tweets," which are currently limited to 140 character spaces per tweet) and online paid search (e.g., "sponsored links" on search engines such as Google and Yahoo, which have limited character spaces as well as other platform-imposed considerations).